Supplemental Figure 1 : Spot test for quinolone hypersensitivity of strain with insertion in Mu gene 9. Wild-type or the insertion mutant with a transposon in Mu gene 9, both containing pBad33-MEcoRII, were diluted from overnight culture to approximately 4 x 10 8 cells/ml. Ten-fold serial dilutions were generated across a 96-well plate and 5 μl of each dilution was spotted onto LB plates with no drug (left panel), ciprofloxacin (Cipro, 0.01 µg/mL, middle panel) or nalidixic acid (Nal, 2 µg/mL, right panel). Plates were photographed after overnight incubation at 37°C.
Supplemental Figure 4. Spot tests for aza-C resistance of rep and dnaK strains.
Spot tests using dnaK and rep cells were conducted as in Supplemental Figure 1 , except the plates contained 0.05% arabinose and aza-C at 5 or 10 µg/mL. Spot tests were conducted to either confirm resistance or to rule out resistance in the microtiter plates due to the slow growing nature of the mutants. Figure 5 : Aza-C sensitivity of dnaK and dksA strains measured at late exponential phase. Panels A and B are comparative titration curves for dnaK and dksA strains respectively (based on the growth curves represented in Supplemental Figure 3 ). The titration curves were calculated similarly to Figure 1 (Aza-C hypersensitivity of mutants expressing M.EcoRII), with the exception that OD 630 were plotted from the time at which the growth rate of the no-drug culture dropped to 90% of the earlier exponential rate.
Supplemental

Supplemental Figure 6: Isobolic test for synergy with Rho inhibitor bicyclomycin.
Growth curves for the indicated HK22 derivatives were measured in each well of a 96well microtitre plate, with varying concentrations of bicyclomycin (right to left) and aza-C (top to bottom). A detailed description of the data analysis and processing can be found in Kuo et al (16) . Briefly, at each concentration of bicyclomycin (Bcm), the concentration of aza-C necessary to inhibit growth by 95% was estimated. In addition, the concentration of bicyclomycin necessary to inhibit growth by 95% (in the absence of the aza-C) was estimated from the bicyclomycin inhibition curve. The dashed lines connect the average determined MIC value of each drug alone. The linearity of the data indicates no drug interaction, implying that inhibition of Rho by bicyclomycin treatment does not increase sensitivity to aza-C. Another method used to test for synergy was the fractional inhibitory concentration (FIC) index ((83) , also see Instructions to Authors for the ASM Journal Antimicrobial Agents and Chemotherapy). For each level of drug A, the FIC is calculated for the first concentration of drug B that gave 95% inhibition with FIC = [(MIC of drug A tested in combination) /(MIC of drug A tested alone)] + [(MIC of drug B-tested in combination) / (MIC of drug B-tested alone)]. The American Society for Microbiology recommends that synergy is supported by FIC index values less than 0.5, while antagonism is supported by FIC index values greater than 4. The FIC values for hepA, greA, and greB were 0.64, 1.01, 0.81, respectively, also indicating no interaction between the drugs. Thus, the FIC values corroborate the isobolic curves. Table 2 : Sequence summary of the dinD::lacZ fusion construct. The sequence of the dinD::lacZ fusion was determined by deep sequencing of DNA from strain JH39, followed by reconstructing the genome sequence using the sequencing program Geneious and NCBI Blast. The sequence of the fusion is summarized here, and can be reconstructed by accessing the sequences and positions listed in descending order in the Table. The order of the numbers in the "Positions" column represents the direction of each sequence fragment in the fusion. The dinD::lacZ fusion was originally created by infecting cells with the Mud(Ap R , lac) phage and isolating strains that induced β-galactosidase activity during mitomycin C treatment (41,84). The Mud(Ap R ,lac) phage contains a temperaturesensitive mutation in the Mu repressor (cts62) which induces phage gene transcription at high temperatures, making the cells temperature sensitive for growth. Strain JH39 was created using the dinD1::MudI(Ap R lac) fusion, but with selection for derivatives that had lost the temperature sensitivity and the ability of the Mu phage to transpose (41,85). The sequence shows an IS1 insertion in gene A of Mu, which explains the loss of transposition. This IS1 element has a 298-bp deletion, with an area of microhomology near the deletion site that may have been involved in the deletion formation. The Mu sequence still contains the cts62 mutation, and therefore another mutation(s) must suppress the temperature sensitivity. Likely candidates are: (1) the IS1 insertion in gene A, because IS1 (including this deletion derivative) carries a transcriptional terminator (86) and the toxic Mu gene kil (also called gene 5) is downstream; and (2) the IS30 element, which interrupts the late gene region of Mu and might thereby prevent expression of one or more toxic late genes. The Mu sequence in this element reveals an inverted repeat of 43 bp near the C end of Mu, most likely due to non-standard fusion formation during the transposition of the MudI(Ap R lac) element into dinD or the fusion/deletion of Mu and trpB (the latter mutation is called ∆FI by Kenyon and Walker; non-standard fusion formation is described in (87)). The Mu sequence also contains a point mutation in gene T. 
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